Results 231 to 240 of about 280,456 (250)
Some of the next articles are maybe not open access.
Atherosclerosis Supplements, 2017
According to current European guidelines, lipid lowering therapy for progressive cardiovascular disease including cardiovascular events has to be focused on a target level for LDL-C. In contrast for Lp(a) a threshold has to be defined with respect to the method of measurement.
V J J, Schettler +7 more
openaire +2 more sources
According to current European guidelines, lipid lowering therapy for progressive cardiovascular disease including cardiovascular events has to be focused on a target level for LDL-C. In contrast for Lp(a) a threshold has to be defined with respect to the method of measurement.
V J J, Schettler +7 more
openaire +2 more sources
Current Topics on Low-Density Lipoprotein Apheresis
Therapeutic Apheresis and Dialysis, 2001The prognosis of patients suffering from severe hyperlipidemia, sometimes combined with elevated lipoprotein (a) (Lp[a]) levels, and coronary heart disease (CHD) refractory to diet and lipid-lowering drugs is poor. For such patients, regular treatment with low-density lipoprotein (LDL) apheresis is the therapeutic option.
R, Bambauer, R, Schiel, R, Latza
openaire +2 more sources
Lipoprotein apheresis: State of the art and novelties
Atherosclerosis Supplements, 2013Lipoprotein apheresis (LA) is an extracorporeal technique which permits the unselective or specific removal of lipoproteins, namely Low Density Lipoproteins (LDL), as well as other apolipoprotein B100-containing lipoproteins from plasma. LA represents a selective upgrade (with both clinical and metabolic advantages) from conventional forms of ...
STEFANUTTI, Claudia, Ulrich Julius
openaire +2 more sources
Low‐Density Lipoprotein Apheresis: Principles and Indications
Seminars in Dialysis, 2012AbstractLow‐density lipoprotein (LDL) apheresis describes a group of apheresis techniques that selectively remove apolipoprotein B‐containing lipoproteins producing an acute reduction in LDL‐cholesterol (LDL‐C). Six devices are available for the removal of LDL‐C while sparing other important plasma components. The LDL‐apheresis (LDL‐A) is not routinely
openaire +2 more sources
Why an Apheresis Center Should Offer More Than One Lipoprotein Apheresis Method
Therapeutic Apheresis and Dialysis, 2012AbstractWe describe our experience with the performance of six lipoprotein apheresis methods (HELP, TheraSorb LDL, DALI, lipidfiltration, Liposorber D, MONET) which have been used in 68 patients. Thirty‐four of them have been treated with more than one method.
Ulrich, Julius +4 more
openaire +2 more sources
Alirocumab in lipoprotein apheresis: A synergy for patients with high-Lp(a).
Transfusion and Apheresis Science, 2023F. Sbrana +3 more
semanticscholar +1 more source
Brief History of Low‐density Lipoprotein Apheresis
Therapeutic Apheresis and Dialysis, 2003Abstract: Low‐density lipoprotein (LDL) apheresis is a technology used to remove LDL from hypercholesterolemic patients. The technique includes both specific and non‐specific removal of LDL such as exchange of the whole plasma and selective adorption of LDL.
openaire +2 more sources
Low-Density Lipoprotein (LDL) Apheresis
2015Low-density lipoprotein (LDL) apheresis, also referred to as lipoprotein apheresis or lipid apheresis, is a procedure that involves extracorporeal treatment of plasma to remove apoprotein (apo) B-containing lipoproteins followed by reinfusion of the processed blood.
openaire +1 more source
Lipoprotein apheresis in pregnancy
Atherosclerosis, 2020A. Pottle, T. Khan, M. Barbir
openaire +1 more source

